In addition to what SanFran noted about missing info regarding repayment of the Citi loan, also missing has been a recent update on the planning/launch of the PNH Complement-Disease trial. It was way back in Sept 2015 that they proposed a Phase 2 pilot trial for PNH. This seems to have taken a back burner to the Kidney trial(s), despite their milestone slide still reading "Phase 2/3 Orphan indication launch – 2016, PNH and/or Dialysis." I vaguely recall in a past webcast that Resverlogix noted some difficulty in finding patients for the PNH trial. Between PNH and renal, I am very happy that they are pursuing the renal indications, since there is such a huge market there and a lot of excitement as exemplified by the EMPA-REG OUTCOME kidney data presented at American Diabetes meeting today.

BearDownAZ